Stay updated on EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.

Latest updates to the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedThe history now includes a newer study update dated 2026-10-26, with revisions covering study status and identification, study design, participant flow, adverse events, and contacts/locations.SummaryDifference0.4%

- Check20 days agoChange DetectedAn NIH-wide banner announces that federal agencies are adopting “Super Intelligence” in place of “Artificial Intelligence” and links to transition updates.SummaryDifference0.3%

- Check27 days agoChange DetectedThe website's footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check34 days agoChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check55 days agoChange DetectedA new revision entry labeled v3.7.0 has been added to the record history, replacing the previous v3.6.6. This indicates an update to the study record history on ClinicalTrials.gov.SummaryDifference0.0%

- Check76 days agoChange DetectedThe record history gains an entry for v3.6.6 and removes the previous v3.6.5 entry, indicating a version update in the study's release history.SummaryDifference0.0%

Stay in the know with updates to EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.